Gene · 150094
Papers4,535
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,535
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Oxidative Stress in Trisomy 21 Phenotype. | Cell Mol Neurobiol | 2023 | 37819608 | PubTator, text mining | PubMed |
| BRAFV600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration. | Sci Rep | 2023 | 37816788 | PubTator, text mining | PubMed |
| TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas. | Head Neck | 2023 | 37815002 | PubTator, text mining | PubMed |
| Non-targeted proteomic analysis of Asian elephant (Elephas maximus) seminal plasma using an in-solution digestion technique and liquid chromatography tandem-mass spectrometry. | Front Vet Sci | 2023 | 37799407 | PubTator, text mining | PubMed |
| Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes. | Cancer Cell Int | 2023 | 37794491 | PubTator, text mining | PubMed |
| Urinary exosome proteins PAK6 and EGFR as noninvasive diagnostic biomarkers of diabetic nephropathy. | BMC Nephrol | 2023 | 37789280 | PubTator, text mining | PubMed |
| Nanoparticle delivery through the BBB in central nervous system tuberculosis. | Ibrain | 2023 | 37786519 | PubTator, text mining | PubMed |
| RBMS3, a downstream target of AMPK, Exerts Inhibitory Effects on Invasion and Metastasis of Lung Cancer. | J Cancer | 2023 | 37781074 | PubTator, text mining | PubMed |
| Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer. | J Endocr Soc | 2023 | 37766843 | PubTator, text mining | PubMed |
| Silibinin Downregulates Types I and III Collagen Expression via Suppression of the mTOR Signaling Pathway. | Int J Mol Sci | 2023 | 37762688 | PubTator, text mining | PubMed |
| Long Noncoding RNA ZBED5-AS1 Facilitates Tumor Progression and Metastasis in Lung Adenocarcinoma via ZNF146/ATR/Chk1 Axis. | Int J Mol Sci | 2023 | 37762228 | PubTator, text mining | PubMed |
| Mimicking Hypoxic-Ischemic Encephalopathy in a Newborn with 21q Deletion Originating from Ring Chromosome 21. | Children (Basel) | 2023 | 37761422 | PubTator, text mining | PubMed |
| Differentiating Benign from Malignant Thyroid Tumors by Kinase Activity Profiling and Dabrafenib BRAF V600E Targeting. | Cancers (Basel) | 2023 | 37760447 | PubTator, text mining | PubMed |
| Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer. | Cells | 2023 | 37759471 | PubTator, text mining | PubMed |
| FunSpace: A functional and spatial analytic approach to cell imaging data using entropy measures. | PLoS Comput Biol | 2023 | 37756338 | PubTator, text mining | PubMed |
| Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients. | Nat Commun | 2023 | 37749078 | PubTator, text mining | PubMed |
| A TaSnRK1α Modulates TaPAP6L-Mediated Wheat Cold Tolerance through Regulating Endogenous Jasmonic Acid. | Adv Sci (Weinh) | 2023 | 37740426 | PubTator, text mining | PubMed |
| The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways. | Cell Commun Signal | 2023 | 37735675 | PubTator, text mining | PubMed |
| ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC. | Clin Cancer Res | 2023 | 37733794 | PubTator, text mining | PubMed |
| CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCs. | J Exp Clin Cancer Res | 2023 | 37723588 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/150094/papers?page=18